Karen Baxter

Stockley's Drug Interactions, edited by Karen Baxter, remains the world's most comprehensive and authoritative reference book on drug interactions. It provides the busy healthcare professional with quick and easy access to clinically relevant, evaluated and evidence-based information on drug interactions.

A Source Book of Interactions, Their Mechanisms, Clinical Importance and Management

Stockley's Drug Interactions

Elizabeth M. Williamson

Samuel Driver

Provides an invaluable reference text for all healthcare professionals who require evidence-based information on the interactions of conventional medicines with herbal medicines, dietary supplements and nutraceuticals. Stockley's Herbal Medicines Interactions is a unique collaboration between a team of experts in the fields of drug interaction, clinical herbal medicines, phytopharmacovigilance and regulation of herbal medicinal products. Stockley's Herbal Medicines Interactions brings together available data on over 150 of the most commonly used herbal medicines dietary supplements and nutraceuticals in highly structured, rigorously researched and fully referenced monographs.

A Guide to the Interactions of Herbal Medicines, Dietary Supplements and Nutraceuticals with Conventional Medicines

Stockley's Herbal Medicines Interactions

Stockley's Drug Interactions, now fully revised and revalidated, remains the world's most comprehensive and authoritative reference book on drug interactions and provides the busy healthcare professional with quick and easy access to clinically relevant, evaluated and evidence-based information on drug interactions. Contains detailed yet concise monographs: covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, pesticides and drugs of abuse; based on published sources and fully referenced; provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance and gives clear guidance on how to manage the interaction in practice; contains over 3,400 monographs; New drugs launched in the last two years added - including drugs such as fesoterodine, several monoclonal antibodies, new antidiabetics (e.g. sitagliptin) new antineoplastics (e.g. dasatinib) and new immunosuppressants (e.g. temsirolimus); updated information on seasonal flu vaccines and antivirals, including all available information on possible interactions with concurrent medication; increased commentary on the involvement of newer mechanisms in drug interactions, such as drug transporter proteins, and other genetic factors that affect the ability of individuals to metabolise medicines.

Karen Baxter

About

Books

Join the club